Harvard Bioscience (HBIO) Net Cash Flow (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.28% |
| Mar 31, 2026 | -173.60% |
| Dec 31, 2025 | 423.62% |
| Sep 30, 2025 | -142.88% |
| Jun 30, 2025 | 15.01% |
| Mar 31, 2025 | 1,221.43% |
| Dec 31, 2024 | -164.90% |
| Sep 30, 2024 | 171.56% |
| Jun 30, 2024 | -271.54% |
| Mar 31, 2024 | 114.07% |
| Dec 31, 2023 | -172.23% |
| Sep 30, 2023 | 119.20% |
| Jun 30, 2023 | 169.61% |
| Mar 31, 2023 | -177.27% |
| Dec 31, 2022 | -148.97% |
| Sep 30, 2022 | 148.26% |
| Jun 30, 2022 | 48.79% |
| Mar 31, 2022 | -200.42% |
| Dec 31, 2021 | 460.34% |
| Sep 30, 2021 | -276.49% |